The story has been updated to include comments from company officials from its earnings conference call.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that its second quarter revenues improved 4 percent year over year, as the company exceeded the average analyst estimates on the top and bottom lines.

Companywide revenues for the three months ended June 29 reached $3.24 billion, up from $3.11 billion a year ago, beating the consensus Wall Street estimate of $3.22 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.